Pregnancy

Fosamprenavir (Telzir) has not been tested for safety and efficacy in pregnant women. However, in the clinical trials that led to fosamprenavir’s European approval, five women exposed to the drug during pregnancy delivered healthy babies.

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.